The impact of perampanel treatment on quality of life and psychiatric symptoms in patients with drug-resistant focal epilepsy: An observational study in Italy.

This study also confirms the importance of a comprehensive clinical assessment, including psychiatric symptoms evaluation before offering a new treatment, to improve therapy compliance. PMID: 31371205 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31371205?dopt=Abstract

Source: Epilepsy and Behaviour - July 28, 2019 Category: Neurology Authors: Deleo F, Quintas R, Turner K, Didato G, Zambrelli E, Pappalardo I, Chiesa V, Pastori C, de Curtis M, Canevini MP, Villani F Tags: Epilepsy Behav Source Type: research